Kava as a Clinical Nutrient: Promises and Challenges.

Area of Science:

• Phytochemistry
• Pharmacology
• Ethnobotany

Background:

• Kava (Piper methysticum) has a long history of traditional use in Pacific Islander cultures.
• Kava extracts were historically used in Europe for anxiety and are now marketed as dietary supplements and recreational drinks globally.
• Emerging research suggests kava possesses anti-inflammatory, anticancer, and neurological benefits.

Purpose of the Study:

• To provide a comprehensive overview of kava use and research for scientists, consumers, and regulators.
• To review the historical background, chemical composition, and therapeutic potential of kava.
• To highlight challenges in kava research, including product standardization and safety concerns.

Main Methods:

• Literature review of historical and current research on kava.
• Analysis of kava's chemical constituents and proposed mechanisms of action.
• Discussion of therapeutic applications and associated risks.

Main Results:

• Kava exhibits potential in treating inflammatory conditions, neurological disorders, and cancer.
• Significant challenges exist due to product variability and lack of standardization.
• Rare cases of hepatotoxicity have been reported, necessitating further investigation into mechanisms and validation.

Conclusions:

• Urgent need for quality control and assurance in kava product manufacturing.
• Further research is required on kava's pharmacokinetics, metabolism, and foundational pharmacology.
• Standardized kava products are essential for safe and effective clinical trials to maximize therapeutic benefits and minimize risks.